Arbemnifosbuvir is a nidovirus DdRp-associated nucleotidyltransferase (NiRAN) domain of non-structural protein 12 (nsp12)-interfering drugs. Arbemnifosbuvir can be used for SARS-CoVs infection research[1].
References:
[1]. Sommadossi, J.P, et al. Niran interfering drugs for sars-cov-2 mutant therapy. The United States, WO2022076903 A1 2022-14-04.
















